EyePoint Pharmaceuticals (EYPT) Free Cash Flow: 2010-2024
Historic Free Cash Flow for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to -$130.3 million.
- EyePoint Pharmaceuticals' Free Cash Flow fell 20372.55% to -$20.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$46.0 million, marking a year-over-year decrease of 66.93%. This contributed to the annual value of -$130.3 million for FY2024, which is 8001.87% down from last year.
- Per EyePoint Pharmaceuticals' latest filing, its Free Cash Flow stood at -$130.3 million for FY2024, which was down 8,001.87% from -$1.6 million recorded in FY2023.
- In the past 5 years, EyePoint Pharmaceuticals' Free Cash Flow registered a high of -$1.6 million during FY2023, and its lowest value of -$130.3 million during FY2024.
- Its 3-year average for Free Cash Flow is -$66.3 million, with a median of -$67.2 million in 2022.
- In the last 5 years, EyePoint Pharmaceuticals' Free Cash Flow soared by 97.61% in 2023 and then crashed by 8,001.87% in 2024.
- Over the past 5 years, EyePoint Pharmaceuticals' Free Cash Flow (Yearly) stood at -$14.8 million in 2020, then crashed by 239.62% to -$50.3 million in 2021, then plummeted by 33.63% to -$67.2 million in 2022, then surged by 97.61% to -$1.6 million in 2023, then slumped by 8,001.87% to -$130.3 million in 2024.